Certification Rate
98.8%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Warren, NY NAICS: 325412
U.S. Department of Labor's OFLC discloses 84 Labor Condition Application filings naming Invagen Pharmaceuticals, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 324 H-1B petitions naming Invagen Pharmaceuticals, Inc. through FY2024, and approved nearly every one of them: 98.5% approved (319 approvals, 5 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Invagen Pharmaceuticals, Inc. is listed in 84 DOL LCA filings, more filings than 97% of employer filers in this extract. DOL certified 98.8% of those LCAs; the median listed offered wage is $97,109. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Warren, NY.
Invagen Pharmaceuticals, Inc. LCA outcome mix
84DOL LCA filings on record
Invagen Pharmaceuticals, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
84 3118th of 122824 higher than 119,706 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $60,549–$185,000 .
DOL LCA release change
On 84 LCAs with comparable offered vs prevailing wages, Invagen Pharmaceuticals, Inc. averages about 14.2% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (47.6% of LCA filings).
Completed-year LCA counts rose from 9 in FY2023 to 36 in FY2025 (≈4×). Cumulative volume: 84.
Certification Rate
98.8%
Very high DOL cert
Avg. Salary
$97,109
Below portal avg
Total Workers
84
Moderate worker count
Compensation range for H-1B positions at Invagen Pharmaceuticals, Inc.
Wage vs. DOL Minimum
+14.2%
At/above DOL floor
national avg +17.8%
Typical DOL Wage Level
Qualified (Level II)
47.6% of LCA filings
Full-Time Positions
100%
Primary Worksite County
SUFFOLK, NY
45.2% of LCA filings
Most frequently listed job titles at Invagen Pharmaceuticals, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| QC Chemist I | 6 | $68,658 |
| QC Chemist II | 5 | $78,600 |
| IT Business Partner | 4 | $104,500 |
| IT Specialist | 3 | $88,333 |
| Formulation Scientist III | 3 | $103,243 |
| Analytical QA Supervisor | 3 | $100,000 |
| Validation Engineer | 2 | $90,000 |
| Senior Scientist | 2 | $125,259 |
| Senior Formulation/Process Scientist | 2 | $125,000 |
| Regulatory Affairs, Associate II | 2 | $85,000 |
| QC Chemist | 2 | $75,000 |
| QA Specialist | 2 | $89,100 |
| Production Planner | 2 | $85,726 |
| Manager of Research and Development | 2 | $118,505 |
| Facilities Engineer | 2 | $83,888 |
Cross-state DOL neighbors for Invagen Pharmaceuticals, Inc. - LCA filing-count and offered-wage axes, outside NY.
Nearest cross-state employer filers by LCA filing count (84 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($97,109 here).
Invagen Pharmaceuticals, Inc. is listed in 84 DOL Labor Condition Application filings covering 84 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Invagen Pharmaceuticals, Inc. ranks #3081 by total LCA filing count (84 filings). 119,706 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Invagen Pharmaceuticals, Inc. has a 98.8% DOL certification rate, with 83 out of 84 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Invagen Pharmaceuticals, Inc.'s LCAs is $97,109. Listed wages range from $60,549 to $185,000 and are not verified actual compensation.
The top job titles in Invagen Pharmaceuticals, Inc.'s LCA filing records include QC Chemist I, QC Chemist II, IT Business Partner. The most common listed title is QC Chemist I with 6 LCA filings at an average listed offered wage of $68,658. This does not establish actual job openings, hiring, or approved petitions.
Invagen Pharmaceuticals, Inc. is headquartered in Warren, NY. Their H-1B workers are distributed across 2 states, with the most positions in NY, MA.
No, Invagen Pharmaceuticals, Inc. is not classified as H-1B dependent.
Invagen Pharmaceuticals, Inc. is listed in 9 LCA filings in FY2023 and 19 in FY2026. The average listed offered wage changed from $101,482 to $90,253. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-CLEAN · WAGE-BELOW.
ABS(total_petitions) peer at 84 LCAs (Δ 0 heavier vs Invagen Pharmaceuticals, Inc.); CERT-SOLID · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-CLEAN · WAGE-BELOW.
ABS(total_petitions) peer at 84 LCAs (Δ 0 heavier vs Invagen Pharmaceuticals, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-CLEAN · WAGE-BELOW.
ABS(total_petitions) peer at 84 LCAs (Δ 0 heavier vs Invagen Pharmaceuticals, Inc.); CERT-CLEAN · WAGE-BELOW vs this page's MICRO-BOOK · CERT-CLEAN · WAGE-BELOW.
ABS(total_petitions) peer at 84 LCAs (Δ 0 heavier vs Invagen Pharmaceuticals, Inc.); CERT-CLEAN · WAGE-ELITE vs this page's MICRO-BOOK · CERT-CLEAN · WAGE-BELOW.
NY pole at 6,144 LCAs stamps HEAVY-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from Invagen Pharmaceuticals, Inc.'s MICRO-BOOK.
Open the NY state board after the ABS peers. Invagen Pharmaceuticals, Inc. stamps MICRO-BOOK · CERT-CLEAN inside that worksite mix.
Invagen Pharmaceuticals, Inc.'s WAGE-BELOW · MICRO-BOOK stamps sit mid-band. Wage levels I-IV explain the floor behind the offer.
What to do with this profile
Use the DOL LCA record for Invagen Pharmaceuticals, Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.